Renaissance Technologies’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,209,700
| Closed | -$2.63M | – | 4546 |
|
|
2022
Q3 | $2.63M | Sell |
2,209,700
-78,600
| -3% | -$93.6K | ﹤0.01% | 1850 |
|
|
2022
Q2 | $4.12M | Buy |
2,288,300
+828,400
| +57% | +$1.49M | ﹤0.01% | 1702 |
|
|
2022
Q1 | $2.95M | Buy |
1,459,900
+849,500
| +139% | +$1.72M | ﹤0.01% | 1936 |
|
|
2021
Q4 | $1.65M | Buy |
610,400
+493,700
| +423% | +$1.34M | ﹤0.01% | 2286 |
|
|
2021
Q3 | $520K | Buy |
+116,700
| New | +$520K | ﹤0.01% | 2877 |
|
|
2019
Q3 | – | Sell |
-84,900
| Closed | -$1.26M | – | 3811 |
|
|
2019
Q2 | $1.26M | Buy |
+84,900
| New | +$1.26M | ﹤0.01% | 2580 |
|
|
2018
Q2 | – | Sell |
-258,000
| Closed | -$13.6M | – | 3618 |
|
|
2018
Q1 | $13.6M | Buy |
+258,000
| New | +$13.6M | 0.01% | 1175 |
|
|
2017
Q3 | – | Sell |
-326,200
| Closed | -$30.5M | – | 3430 |
|
|
2017
Q2 | $30.5M | Buy |
326,200
+172,800
| +113% | +$16.2M | 0.04% | 608 |
|
|
2017
Q1 | $9.77M | Buy |
153,400
+71,300
| +87% | +$4.54M | 0.01% | 1264 |
|
|
2016
Q4 | $3.65M | Buy |
+82,100
| New | +$3.65M | 0.01% | 1875 |
|
|
2016
Q3 | – | Sell |
-307,200
| Closed | -$4.22M | – | 3540 |
|
|
2016
Q2 | $4.22M | Sell |
307,200
-208,200
| -40% | -$2.86M | 0.01% | 1710 |
|
|
2016
Q1 | $9.9M | Buy |
+515,400
| New | +$9.9M | 0.02% | 1140 |
|
|
2015
Q4 | – | Sell |
-128,900
| Closed | -$11.9M | – | 3482 |
|
|
2015
Q3 | $11.9M | Buy |
+128,900
| New | +$11.9M | 0.03% | 837 |
|
|
2014
Q4 | – | Sell |
-22,000
| Closed | -$998K | – | 3176 |
|
|
2014
Q3 | $998K | Buy |
+22,000
| New | +$998K | ﹤0.01% | 2025 |
|
|
2013
Q4 | – | Sell |
-14,200
| Closed | -$863K | – | 3069 |
|
|
2013
Q3 | $863K | Sell |
14,200
-7,200
| -34% | -$438K | ﹤0.01% | 2074 |
|
|
2013
Q2 | $1.43M | Buy |
+21,400
| New | +$1.43M | ﹤0.01% | 1767 |
|